Intrexon Bioinformatics Germany GmbH, commonly referred to as Intrexon, is a leading player in the bioinformatics industry, headquartered in Germany. Founded in 2000, the company has established itself as a pioneer in providing innovative solutions for genomic data analysis and interpretation, catering to a diverse range of sectors including pharmaceuticals, biotechnology, and healthcare. With a strong operational presence across Europe, Intrexon offers unique core services such as advanced bioinformatics platforms and data analytics tools that enhance research efficiency and accuracy. The company is recognised for its commitment to integrating cutting-edge technology with biological insights, positioning itself as a trusted partner in the life sciences sector. Intrexon's notable achievements include significant contributions to genomic research, solidifying its market position as a key innovator in bioinformatics.
How does Intrexon Bioinformatics Germany GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Intrexon Bioinformatics Germany GmbH's score of 20 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Intrexon Bioinformatics Germany GmbH, headquartered in Germany, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. Furthermore, there are no documented reduction targets or climate pledges associated with the company. As a current subsidiary of Intrexon Bioinformatics Germany GmbH, any potential climate commitments or emissions data may be cascaded from its parent organisation. However, no specific initiatives or targets have been identified at this level either. In the context of the industry, it is essential for companies like Intrexon Bioinformatics Germany GmbH to establish clear climate commitments and reduction strategies to align with global sustainability goals. Without reported emissions or reduction initiatives, the company may face challenges in demonstrating its commitment to addressing climate change.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Intrexon Bioinformatics Germany GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
